Immix Biopharma, Inc. Interest Expense
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-03-29
- Immix Biopharma, Inc. interest expense for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Immix Biopharma, Inc. interest expense for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Immix Biopharma, Inc. interest expense for the quarter ending 2022-06-30 was $109.00, a 99.80% decline year-over-year.
- Immix Biopharma, Inc. interest expense for the quarter ending 2022-03-31 was $388.00, a 98.59% decline year-over-year.
- Immix Biopharma, Inc. interest expense for fiscal 2022 was $497.00, a 99.72% decline from fiscal 2021.
- Immix Biopharma, Inc. interest expense for fiscal 2021 was $179.85K, a 76.37% increase from fiscal 2020.
- Immix Biopharma, Inc. interest expense for fiscal 2020 was $101.98K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $0.00 derived: sum of 2 quarters · filed 2024-03-29 | $109.00 derived: sum of 3 quarters · filed 2024-03-29 | $497.00 10-K · filed 2024-03-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $109.00 derived: sum of 2 quarters · filed 2023-11-13 | $497.00 10-Q · filed 2023-11-13 | $45.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $109.00 10-Q · filed 2023-08-11 | $497.00 10-Q · filed 2023-08-11 | $45.00K derived: sum of 3 quarters · filed 2023-08-11 | $98.94K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $388.00 10-Q · filed 2023-05-12 | $44.90K derived: sum of 2 quarters · filed 2023-05-12 | $98.83K derived: sum of 3 quarters · filed 2023-05-12 | $152.70K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $44.51K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $98.44K derived: sum of 2 quarters · filed 2023-03-27 | $152.31K derived: sum of 3 quarters · filed 2023-03-27 | $179.85K 10-K · filed 2023-03-27 |
| 2021-09-30 | $53.94K 10-Q · filed 2022-11-09 | $107.80K derived: sum of 2 quarters · filed 2022-11-09 | $135.35K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $53.87K 10-Q · filed 2022-08-12 | $81.41K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $27.54K 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $101.98K 10-K · filed 2022-03-28 |